City of Hope recently announced the following new staff additions.
Bart O. Roep, PhD
Internationally recognized immunologist Bart O. Roep, PhD, has joined City of Hope as Chair of the Department of Diabetes Immunology within the Diabetes & Metabolism Research Institute. An expert in the potential of immune therapy to treat type 1 diabetes, Dr. Roep will expand the institution’s emphasis on developing new approaches to the treatment and cure of diabetes. Dr. Roep is also known for his focus on T cells and his groundbreaking use of immunotherapy in the treatment of hematologic malignancies.
Dr. Roep comes to City of Hope from Leiden University Medical Center in the Netherlands, where he served as Head of the Division of Autoimmunity and Professor of Medicine, Diabetology, Immunopathology, and Immune Intervention Therapy. He earned his doctorate from Leiden University.
Veronica Jones, MD
Veronica Jones, MD, has joined City of Hope as an Assistant Clinical Professor in the Department of Surgery, specializing in breast surgery. Dr. Jones joins City of Hope from Emory University, where she was Assistant Professor in the Department of Surgery.
While in medical school, she was inducted into the Alpha Omega Alpha National Medical Honor Society, and traveled to Kenya to complete clerkships in HIV/AIDS and reproductive health. Dr. Jones continued her postdoctoral training at Baylor University Medical Center, with a categorical general surgery internship and residency. At Baylor, Dr. Jones was honored as Chief Resident of the year. In 2014, she completed a breast surgical oncology fellowship at Emory University.
She received her medical degree from Meharry Medical College in Nashville, Tennessee.
Daneng Li, MD
Daneng Li, MD, has joined City of Hope as Assistant Clinical Professor in the Department of Medical Oncology and Therapeutics, specializing in geriatric and gastrointestinal oncology.
Dr. Li received his medical degree from Weill Cornell Medical College, before pursuing an internship and residency in internal medicine at New York-Presbyterian Hospital/Weill Cornell Medical Center. He recently completed a hematology/oncology fellowship at Memorial Sloan Kettering Cancer Center. ■
